Most Read Articles
Elaine Soliven, 4 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
Stephen Padilla, 4 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 3 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.

Snoring portends subsequent stroke-related events in selected OSA patients

31 Jul 2020

Among obstructive sleep apnoea (OSA) patients with cardiovascular disease (CVD), snoring is tied to greater risks of cerebral but not cardiac events, independent of OSA severity and continuous positive airway pressure (CPAP) treatment, according to data from the Sleep Apnea cardiovascular Endpoints (SAVE) trial.

Researchers conducted a posthoc analysis of the SAVE trial involving 2,687 OSA patients with established coronary or cerebral CVD who were randomly allocated to CPAP treatment plus usual care or usual care alone. The present analysis included 2,540 patients (94.5 percent) who had at least two measurements of frequency and loudness, and 2,590 patients (96.5 percent) who had at least two measurements of breathing pauses during follow-up (median, 3.5 years).

Patients who reported frequent snoring where more likely to be young, of Asian ethnicity, use tobacco, have a history of cerebrovascular disease, consume alcohol infrequently, and have higher diastolic blood pressure (BP) and apnoea-hypopnea index, among others.

Multivariable Cox proportional hazards model showed that the risk of primary composite CV outcome was associated with increased snoring frequency (adjusted hazard ratio [aHR], 1.10, 95 percent confidence interval [CI], 1.02–1.20; p=0.015), loudness (aHR, 1.16, 95 percent CI, 1.06–1.27; p=0.001), and breathing pauses (aHR, 1.16, 95 percent CI, 1.08–1.25; p<0.001) at any timepoint during follow-up.

Of note, the associations were driven by a higher incidence of cerebral rather than cardiac events, as well as positive interactions between the three snoring patterns for cerebral events. There was no significant interaction between CPAP treatment and snoring variables for cerebral events.

More studies are needed to elucidate the pathophysiology underlying snoring and stroke incidence, as well as trials investigating effective interventions for snoring in patients with OSA, according to the researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elaine Soliven, 4 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
Stephen Padilla, 4 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 3 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.